Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental tetracaine poisoning |
Causative agent |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Intentional tetracaine poisoning |
Causative agent |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
forgiftning med tetracain, uvist med hvilken hensigt |
Causative agent |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Allergy to tetracaine |
Causative agent |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 2 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 1 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 0,5 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracain 4 % gel + forbinding |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracain 4 % gel + okkluderende forbinding |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracain til topisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 0,2 %/glucose 6% injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 0,3 %/glucose 6 % injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 1 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 10 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 5 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
tetracainhydrochlorid 3 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Product containing tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Poisoning by tetracaine |
Causative agent |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Tetracaine measurement |
Component |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Chlorhexidine gluconate+amethocaine hydrochloride 0.05%/0.015% throat spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Chlorhexidine digluconate+amethocaine 0.05/0.015% oral spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Eludril oral spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Tetracaine hydrochloride |
Is a |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Amethocaine adverse reaction |
Causative agent |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Intentional tetracaine poisoning |
Causative agent |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Adverse reaction to tetracaine |
Causative agent |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
lidocain 70 mg + tetracain 70 mg depotplaster |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Product containing chlorhexidine and tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
tetracain til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Product containing tetracaine in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Tetracaine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Accidental poisoning by tetracaine |
Causative agent |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Allergy to tetracaine |
Causative agent |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
|
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Product containing tetracaine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing lidocaine and tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Chlorhexidine and tetracaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only tetracaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine and tetracaine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing only lidocaine and tetracaine in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Tetracaine only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Tetracaine only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Tetracaine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Tetracaine only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only chlorhexidine and tetracaine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Product containing chlorhexidine and tetracaine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Product containing tetracaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Chlorhexidine- and tetracaine-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |
Product containing only chlorhexidine and tetracaine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracaine (substance) |
Inferred relationship |
Some |
2 |